Suppr超能文献

通过将小鼠脾细胞与携带肽/同种异体主要组织相容性复合体的自体巨噬细胞共培养来培养同种异体限制性细胞毒性T淋巴细胞。

Raising allo-restricted cytotoxic T lymphocytes by co-culture of murine splenocytes with autologous macrophage bearing the peptide/allo-major histococompatibility complex.

作者信息

Chen Xueling, Yan Yongxiang, Lu Shengjun, Weng Xiufang, Liang Zhihui, Li Jianan, Zhong Maohua, Tang Jie, Xiao Wei, Sun Wei, Shen Guanxin, Wu Xiongwen

机构信息

Department of Immunology, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China.

出版信息

Hum Immunol. 2009 Feb;70(2):79-84. doi: 10.1016/j.humimm.2008.11.005. Epub 2008 Dec 25.

Abstract

Generation and adoptive transfusion of alloreactive cytotoxic T lymphocytes (CTLs) specific for tumor are expected to circumvent tumor tolerance. Here we describe a novel protocol to raise allo-restricted, peptide-specific CTLs by co-culture of murine splenocytes and autologous macrophage bearing an allogeneic H-2K molecule associated with its restricted peptide (peptide/allo-MHC). The extracellular domains of H-2K(d) were fused with constant domains of murine IgG2a heavy chain to generate a fusion protein (peptide/H-2K(d)/IgG2aFc, the dimer) consisting of divalent TCR-ligands and an IgG Fc receptor type I (FcgammaRI)-reactive moiety. The dimer is able to bind to macrophage (Mvarphi) of H-2K(k) via the interaction of the Fc part with FcgammaRI, and cause the H-2K(k) Mvarphi to be coated with the peptide/H-2K(d) complex. The results show that proliferation of CD8+ cells is enhanced and that the specific-tetramer stained CD8+ cells appear more frequently by co-culture of H-2K(k) splenocytes with the autologous Mvarphi loaded with the dimer. Furthermore, the CD8+ T cells from the co-cultural bulk exhibit an elevated cytotoxicity against a specific target (H-2K(d)-restricted, peptide-specific cytotoxicity), compared with that against the irrelevant targets. This study provides a strategy for preparation of allo-restricted, peptide-specific CTLs, which may add to our arsenal for adoptive immunotherapy to eliminate chronic virally infected or tumor cells.

摘要

生成并过继输注针对肿瘤的同种异体反应性细胞毒性T淋巴细胞(CTL)有望克服肿瘤耐受性。在此,我们描述了一种新方案,通过将小鼠脾细胞与携带与其限制性肽相关的同种异体H-2K分子的自体巨噬细胞共培养来培养同种异体限制性、肽特异性CTL(肽/同种异体MHC)。将H-2K(d)的细胞外结构域与小鼠IgG2a重链的恒定结构域融合,以生成一种融合蛋白(肽/H-2K(d)/IgG2aFc,二聚体),其由二价TCR配体和I型IgG Fc受体(FcγRI)反应性部分组成。该二聚体能够通过Fc部分与FcγRI的相互作用与H-2K(k)的巨噬细胞(Mφ)结合,并使H-2K(k) Mφ被肽/H-2K(d)复合物包被。结果表明,通过将H-2K(k)脾细胞与负载二聚体的自体Mφ共培养,CD8+细胞的增殖增强,并且特异性四聚体染色的CD8+细胞出现得更频繁。此外,与针对无关靶标的细胞毒性相比,来自共培养群体的CD8+ T细胞对特定靶标表现出更高的细胞毒性(H-2K(d)限制性、肽特异性细胞毒性)。本研究提供了一种制备同种异体限制性、肽特异性CTL的策略,这可能会增加我们用于过继免疫疗法以消除慢性病毒感染或肿瘤细胞的手段。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验